Condition

Intraoperative Complications

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions4

Lead sponsors shown3

Clinical trials

3 shown

The Use of Surgical Pleth Index in Guiding Anesthesia in Gastroenterological SurgeryNCT04519203 · 2020-09-09

COMPLETED

Hemodilution and Outcome in Cardiac SurgeryNCT00364494 · 2006-11-01

TERMINATED

TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)NCT00293514 · 2006-02-01

COMPLETED

Common interventions

Different timing of red blood cells transfusion (substudy 1); Acute hemodilution versus no hemodilution (substudy 2)PROCEDURE1 Fibrinogen (human) + thrombin (human) (TachoSil)DRUG1 SPIDEVICE1 StandardDEVICE1

Leading sponsors

Nycomed 1 Tampere University Hospital 1 Università Vita-Salute San Raffaele 1

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

NA2

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.